CLOSED - Clinical Trial on RSV Vaccine TBD

Join the fight against respiratory syncytial virus (RSV)

RSV research studies are now enrolling.

Those who qualify may receive*:

- Payment of up to $440
- Study-related care from local doctors at no cost
- Study medication at no cost
- Compensation for time and travel

There is no obligation, so see if you may qualify now.

Participants are accepted from following cities:
Albuquerque, NM
Atlanta, GA
Atlantis, FL
Austin, TX
Beachwood, OH
Beaumont, TX
Binghamton, NY
Bristol, TN
Butte, MT
Cary, NC
Cedar Park, TX
Champaign, IL
Charlotte, NC
Chula Vista, CA
Cincinnati, OH
Coral Gables, FL
Danville, VA
Deland, FL
Des Peres, MO
Eatonton, GA
Edgewater, FL
El Dorado, KS
Elkridge, MD
Endwell, NY
Evansville, IN
Fort Collins, CO
Fort Myers, FL
Gaffney, SC
Grants Pass, OR
Greensboro, NC
Gulfport, MS
Jacksonville, FL
Kansas City, MO
Knoxville, TN
La Mesa, CA
Lafayette, LA
Lake Charles, LA
Las Vegas, NV
Louisville, KY
Medford, OR
Meridian, ID
Metairie, LA
Miami, FL
Mobile, AL
Monroe, NC
Mount Pleasant, SC
Nashville, TN
New Orleans, LA
New York, NY
Newport News, VA
Newton, KS
Norfolk, NE
Norfolk, VA
Norman, OK
Oklahoma City, OK
Omaha, NE
Orlando, FL
Phoenix, AZ
Pittsburgh, PA
Plano, TX
Redding, CA
Rochester, NY
San Antonio, TX
Savannah, GA
Sioux City, IO
South Bend, IN
Spartanburg, SC
Spring Valley, CA
St. Petersburg, FL
Stockbridge, GA
Tempe, AZ
Tomball, TX
Valparaiso, IN
West Des Moines, IO
West Jordan, Utah
West Palm Beach, FL
Wichita, KS
Wilmington, NC
Winchester, VA
Winston-Salem, NC
Yukon, OK

Space is limited, subject to availability. Criteria for qualification is subject to change at any time, and without notice.